1. Home
  2. PTMN vs NKTX Comparison

PTMN vs NKTX Comparison

Compare PTMN & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTMN
  • NKTX
  • Stock Information
  • Founded
  • PTMN 2006
  • NKTX 2015
  • Country
  • PTMN United States
  • NKTX United States
  • Employees
  • PTMN N/A
  • NKTX N/A
  • Industry
  • PTMN Finance: Consumer Services
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PTMN Finance
  • NKTX Health Care
  • Exchange
  • PTMN Nasdaq
  • NKTX Nasdaq
  • Market Cap
  • PTMN 142.6M
  • NKTX 170.8M
  • IPO Year
  • PTMN N/A
  • NKTX 2020
  • Fundamental
  • Price
  • PTMN $14.08
  • NKTX $1.91
  • Analyst Decision
  • PTMN Hold
  • NKTX Strong Buy
  • Analyst Count
  • PTMN 1
  • NKTX 6
  • Target Price
  • PTMN $16.00
  • NKTX $15.00
  • AVG Volume (30 Days)
  • PTMN 54.0K
  • NKTX 2.4M
  • Earning Date
  • PTMN 05-07-2025
  • NKTX 03-26-2025
  • Dividend Yield
  • PTMN 15.46%
  • NKTX N/A
  • EPS Growth
  • PTMN N/A
  • NKTX N/A
  • EPS
  • PTMN N/A
  • NKTX N/A
  • Revenue
  • PTMN $62,432,000.00
  • NKTX N/A
  • Revenue This Year
  • PTMN N/A
  • NKTX N/A
  • Revenue Next Year
  • PTMN $4.14
  • NKTX N/A
  • P/E Ratio
  • PTMN N/A
  • NKTX N/A
  • Revenue Growth
  • PTMN N/A
  • NKTX N/A
  • 52 Week Low
  • PTMN $13.90
  • NKTX $1.31
  • 52 Week High
  • PTMN $20.84
  • NKTX $10.34
  • Technical
  • Relative Strength Index (RSI)
  • PTMN 16.81
  • NKTX 55.16
  • Support Level
  • PTMN $14.30
  • NKTX $1.76
  • Resistance Level
  • PTMN $15.69
  • NKTX $2.34
  • Average True Range (ATR)
  • PTMN 0.42
  • NKTX 0.16
  • MACD
  • PTMN -0.13
  • NKTX 0.06
  • Stochastic Oscillator
  • PTMN 7.14
  • NKTX 58.25

About PTMN Portman Ridge Finance Corporation

Portman Ridge Finance Corp Inc is a non-diversified closed-end investment company. The company originates, structures, and invests in secured term loans, bonds or notes, and mezzanine debt primarily in privately-held middle market companies but may also invest in other investments such as loans to publicly traded companies, high-yield bonds, and distressed debt securities. The company's investment objective in the Debt securities portfolio is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt, and selected equity investments in privately-held middle market companies.

About NKTX Nkarta Inc.

Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.

Share on Social Networks: